Neurenati Therapeutics

Developer of novel regenerative therapies intended for the treatment of Hirschsprung disease. The company focuses on developing innovative therapy via growth factor to treat newborns with Hirschsprung...

Healthcare

Montreal, Canada

Founded 2020

5 employees

Website

Valuation

$6.4M

Market implied

Share Price

N/A

Total Raised

$4.3M

Last Round

N/A

Investors

+3 other investors

View all 3 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Neurenati Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required